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Abstract
Background and Purpose
The impact of excess body weight on prognosis after stroke is controversial. Many studies
report higher survival rates in obese patients (“obesity paradox”). Recently, obesity has
been linked to worse outcomes after intravenous (IV) thrombolysis, but the number and
sample size of these studies were small. Here, we aimed to assess the relationship
between body weight and stroke outcome after IV thrombolysis in a large cohort study.
Methods
In a prospective observational multicenter study, we analyzed baseline and outcome data
of 896 ischemic stroke patients who underwent IV thrombolysis. Patients were categorized
according to body mass index (BMI) as underweight (<18.5 kg/m2), normal weight (18.5–
24.9 kg/m2), overweight (25–29.9 kg/m2), obese (30–34.9 kg/m2) or severely obese (>35
kg/m2). Using uni- and multivariate modeling, we assessed the relationship of BMI with
favorable outcome (defined as modified Rankin Scale 0 or 1) and mortality 3 months after
stroke as well as the occurrence of symptomatic intracerebral hemorrhages (sICH). We
also measured the incidence of patients that had an early neurological improvement of
>40% on the National Institutes of Health Stroke Scale (NIHSS) after 24 hours.
Results
Among 896 patients, 321 were normal weight (35.8%), 22 underweight (2.5%), 378 over-
weight (42.2%), 123 obese (13.7%) and 52 severely obese (5.8%). Three-month mortality
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was comparable in obese vs. non-obese patients (8.1% vs. 8.3%) and did not differ signifi-
cantly among different BMI groups. This was also true for favorable clinical outcome, risk of
sICH and early neurological improvement on NIHSS at 24 hours. These results remained
unchanged after adjusting for potential confounding factors in the multivariate analyses.
Conclusion
BMI was not related to clinical outcomes in stroke patients treated with IVT. Our data sug-
gest that the current weight-adapted dosage scheme of IV alteplase is appropriate for dif-
ferent body weight groups, and challenge the existence of the obesity paradox after stroke.
Introduction
Stroke and obesity are both characterized by increasing incidence worldwide, causing huge
socio-economic costs [1]. While obesity is an established risk factor for stroke occurrence, its
impact on outcome after stroke is controversial. Many studies suggest survival benefit and bet-
ter clinical outcome in obese stroke patients as compared to their normal weight counterparts
[2–4]. This observation has already been described in many other conditions such as heart fail-
ure, and is termed as “obesity paradox” [4]. The relationship between obesity and stroke out-
come after intravenous thrombolysis (IVT) is less clear due to scarce number of studies with
small sample size and contradictory results. This issue is of clinical relevance, as obesity espe-
cially affects younger people with increase of stroke risk and thus higher probability for IVT.
Therefore, we aimed to investigate clinical outcomes after IVT in a large cohort of patients
with acute ischemic stroke (AIS) according to bodymass index (BMI).
Methods
As a joint initiative of four Swiss stroke centers (Berne, Zurich, Lausanne, St. Gallen), we per-
formed a large prospectivemulticenter study to determine the impact of body weight on stroke
outcome after IVT (data collection from 2003 to 2014). Patients needed to meet the following
two criteria for study inclusion: 1. Treatment with IVT (alteplase) for AIS according to the cur-
rent guidelines of the European Stroke Organization [5], 2. Availability of bodymass index
(BMI) at baseline and outcome data at 3 months. Data from individual patients were systemati-
cally and prospectively collected in each center by using a standardized form with pre-defined
variables as applied in previous studies [6]. Compilation of completed forms from all centers
and analyses of the pooled data were performed in the coordinating center in Berne, Switzer-
land. Detailed data on the number of consecutive patients and study period for each center are
available as supplemental material. The study was approved by local ethics committees of the
individual study centers in Berne (Kantonale Ethikkomission BernNr. 231/2014), St. Gallen
(Kantonale Ethikkomission St. Gallen Nr. 280/09), Zurich (Kantonale Ethikkomission Zürich
Nr. 2013–0105) and Lausanne (Kantonale EthikkommisionWaadt Nr. 40/07). Patients records
were recorded and de-identified prior to analysis. According to the approvals, we did not need
informed consent from individuals for retrospective data. All clinical investigations were con-
ducted according to the principles expressed in the Declaration of Helsinki.
The following variables were prospectively collected in all participating centers: age, sex,
vascular risk factors according to predefined criteria [7], history of coronary artery disease,
antithrombotic medication at stroke onset, initial stroke severity as assessed by the National
BMI and IV Thrombolysis Outcome
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Institutes of Health Stroke Scale (NIHSS) score [8], stroke etiology according to the Trial of
ORG 10172 in Acute Stroke Treatment (TOAST) criteria [9], stroke onset-to-treatment time
as well as blood pressure and blood glucose level obtained at admission. All patients treated
with IVT were admitted to intermediate or intensive care units for at least 24 hours. All
patients underwent brain imaging with computed tomography or magnetic resonance imaging
24 to 48 hours after IVT and in any case of clinical deterioration.
Body Mass Index Assessment
Bodymass index (BMI) was calculated as weight in kilograms divided by height squared in
meters. Body weight and height were either measured by nurses or—if not applicable—esti-
mated by the attending stroke physician during the hospital stay. For obesity measures, we
adopted the following BMI threshold categories fromWorld Health Organization (WHO):
<18.5 kg/m2 for underweight, 18.5 to 24.9 kg/m2 for normal weight, 25.0 to 29.9 kg/m2 for
overweight, 30.0 to 34.9 kg/m2 for obesity and35 kg/m2 for severe obesity [10].
Assessment of Outcomes
Clinical outcomes were assessed during outpatient visits using the modifiedRankin Scale
(mRS) score at 3 months [11]. Main outcome measures in this study were (i) favorable out-
come (defined as mRS 0 or 1), (ii) good outcome (defined as mRS 0 to 2), (iii) death within 3
months and (iv) symptomatic intracerebral hemorrhage (sICH) according to the definition of
the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) [12]. In
addition, we also used the early neurological improvement by>40% on NIHSS at 24 hours
after IVT as a marker of early arterial recanalization [13].
Statistical Analyses
Descriptive statistics are presented as median and interquartile range (IQR) for the continuous
parameters, and number and percentages of total for the categorical variables if not stated dif-
ferently. Outcomemeasures were compared with BMI as a categorical variable and as a contin-
uous variable. The category with normal body weight (BMI 18.5 to 24.9 kg/m2) served as
reference group. We compared demographic and baseline characteristics among different BMI
categories by using Fisher exact test or the chi-square test for categorical variables and the
Mann-Whitney U test for continuous variables. Univariate analysis of the effect of BMI catego-
ries on different outcomes was assessed with logistic regression models, results were presented
as estimated odds ratios and corresponding 95% confidence intervals (95% CI). Besides the
univariate analysis, adjusted effects of BMI categories on different outcomes were of interest.
For the adjustment, the following set of potential confounders was identified a-priori according
to the current literature [7]: age, gender, baseline NIHSS score, smoking, history of hyperten-
sion, systolic blood pressure at presentation, history of cardiovascular disease, history of diabe-
tes, blood glucose at admission, dyslipidemia, antithrombotic treatment at stroke onset, atrial
fibrillation and symptom onset-to-treatment time.
In order to find those variables among the set of potential confounders that influenced the
individual outcome, pairwise correlations between the potential confounder and the outcome
were assessed. In the final multiple models each confounder with a statistically significant rela-
tionship with the outcome was included, in addition to the determinant BMI category [14].
Finally, the interaction of the confounders with the BMI subgroups was tested for significance.
Complete data sets were available for BMI. However, there were missing values in the con-
founders. Multiple imputation using chained equations and five replications (m = 5) were used
for each outcome and corresponding regression analysis. Rubin’s formula was used for the
BMI and IV Thrombolysis Outcome
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combination of effect estimates and their standard errors from the multiply imputed datasets.
We additionally evaluated each confounder for the presence of an interaction term with BMI.
The interaction was deleted from the model, if it was not significantly different from zero. Sta-
tistical analyses were conducted by using the statistical software R (R Core Team (2015)). R: A
language and environment for statistical computing. R Foundation for Statistical Computing,
Vienna, Austria. URL https://www.R-project.org) and the R-package “mice” [15]. The level of
statistical significancewas set to 0.05.
Results
A total of 896 patients were eligible for this study. Of these, 321 were of normal weight (35.8%,
median BMI 23 kg/m2), 22 were underweight (2.5%, median BMI 17.7 kg/m2), 378 overweight
(42.2%, median BMI 27 kg/m2), 123 obese (13.7%, median BMI 31 kg/m2) and 52 severely
obese (5.8%, median BMI 37 kg/m2). The main baseline characteristics of the study population
are detailed in S1 Table.
Gender was differently distributed among BMI categories with a higher percentage of
females in the underweight group (72.7%) as compared to patients with normal weight
(46.4%), overweight (33.3%) or obesity (40.0%). In obese and severely obese patients, the prev-
alence of arterial hypertension, diabetes mellitus, blood glucose at admission and use of antith-
rombotics at stroke onset were significantly higher as compared to the normal weight group,
whereas the baselineNIHSS score tended to be slightly lower. Age and other baseline character-
istics were similar in all BMI groups S1 Table.
At 3 months, patients with a BMI<30 kg/m2 (non-obese) showed no significant difference
for any of the outcome measures in comparison to those with a BMI30 kg/m2 (obese), even
after adjusting for confounding variables (Table 1). The adjusted analysis for sICH was identi-
cal to the univariate analysis because none of the potential confounders was significantly asso-
ciated with sICH.
As compared to the normal weight reference group, none of the BMI categories significantly
differed with respect to the outcomes clinical recovery, mortality, occurrence of sICH, or early
NIHSS improvement (Table 2). In univariate analyses, the following variables were associated
with clinical endpoints (favorable outcome, good outcome, mortality): age, stroke severitymea-
sured by baseline NIHSS score, diabetes mellitus and baseline blood glucose. In addition, mor-
tality was associated with the presence of atrial fibrillation. Predictors of early NIHSS
Table 1. Comparison of Outcomes in patients with BMI30 kg/m2 vs. <30 kg/m2.
Outcome measures Unadjusted analysis Adjusted analysis†
BMI30 kg/m2 BMI <30 kg/m2 OR [95% CI] p value OR [95% CI] p value
Favorable outcome (mRS 0–1) 76/161 (47.2%) 278/660 (42.1%) 1.229 [0.869–1.736] 0.243 1.392 [0.926–2.093] 0.105
Good outcome (mRS 0–2) 101/161 (62.7%) 435/660 (65.9%) 0.871 [0.609–1.245] 0.448 0.845 [0.556–1.286] 0.423
Mortality 13/161 (8.1%) 55/660 (8.3%) 0.966 [0.514–1.815] 0.915 1.065 [0.503–2.255] 0.866
sICH 6/170 (3.5%) 18/698 (2.6%) 1.382 [0.540–3.537] 0.500 1.382 [0.540–3.537] 0.500
Early NIHSS improvement 84/156 (53.8%) 324/648 (50.0%) 1.167 [0.822–1.656] 0.389 1.270 [0.876–1.843] 0.199
Compared to the patients with BMI >30 kg/m2, patients with BMI <30 kg/m2 did not differ in mortality, early NIHSS improvement, favorable or good
functional outcome, or risk for sICH. These results did not change after adjusting for known confounders (†): age, gender, baseline NIHSS score, blood
glucose at admission, systolic blood pressure at admission, smoking, presence of arterial hypertension, presence of diabetes, dyslipidemia, history of
cardiovascular disease, antithrombotic treatment at stroke onset, atrial fibrillation and symptom onset-to-treatment time. Results are presented as odds
ratio with 95% confidence intervals. Abbreviations: BMI (body mass index), OR (odds ratio), CI (confidence interval), IQR (inter quartile range), mRS
(modified Rankin Scale), sICH (symptomatic intracerebral hemorrhage), NIHSS (National Institute of Health Stroke Scale).
doi:10.1371/journal.pone.0164413.t001
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improvement in univariate analysis were age, diabetes mellitus, baseline blood glucose and sys-
tolic blood pressure at admission. For sICH nomodel could be fitted due to singularity because
no sICH was observed in the group of underweight and severely obese patients.
Univariate analyses showed no association between different BMI categories and functional
outcome, mortality or the occurrenceof sICH. BMI categories set in reference to normal weight
patients and were defined as follows:<18.5 kg/m2 for underweight, 18.5 to 24.9 kg/m2 for nor-
mal weight, 25.0 to 29.9 kg/m2 for overweight, 30.0 to 34.9 kg/m2 for obesity and35 kg/m2
for severe obesity. Results are presented as odds ratio with 95% confidence intervals. () Asterix
labels the normal weight reference group. Letters a–d denote significant associations in univari-
ate analysis (see footnotes). Abbreviations: BMI (bodymass index), OR (odds ratio), CI (confi-
dence interval),mRS (modifiedRankin Scale), sICH (symptomatic intracerebral hemorrhage),
NIHSS (National Institute of Health Stroke Scale), n.a. (not applicable).
After multivariate analyses, the outcomes still did not differ among BMI categories as com-
pared to the normal weight group (Table 3). Although underweight patients showed a trend
towards a favorable outcome (mRS 0–1), one has to consider the broad confidence intervals.
Table 2. Univariate outcome analyses according to BMI categories.
Outcome measures BMI categories n/N (%) OR [95% CI]
Normal weight*
(n = 321)
Underweight (n = 22) Overweight (n = 378) Obesity (n = 123) Severe Obesity
(n = 52)
Favourable outcome
(mRS 0–1) a
114/291 (39.2%) 12/21 (57.1%) 2.070
[0.845–5.070]
152/348 (43.7%) 1.204
[0.877–1.653]
56/114 (49.1%) 1.499
[0.969–2.319]
20/47 (42.6%) 1.150
[0.616–2.147]
Good outcome (mRS
0–2) b
194/291 (66.7%) 14/21 (66.7%) 1.000
[0.391–2.559]
227/348 (65.2%)0.938
[0.675–1.303]
75/114 (65.8%) 0.962
[0.609–1.519]
26/47 (55.3%) 0.619
[0.331–1.156]
Mortality c 23/291 (7.9%) 1/21 (4.8%) 0.583
[0.075–4.539]
31/348 (8.9%) 1.139
[0.649–2.002]
8/114 (7.0%) 0.879
[0.381–2.028]
5/47 (10.6%) 1.387
[0.500–3.848]
sICH 11/309 (3.6%) 0/22 (0%) n.a. 7/367 (1.9%) 0.527
[0.202–1.376]
6/120 (5.0%) 1.426
[0.515–3.946]
0/50 (0%) n.a.
Early NIHSS
improvement d
135/283 (47.7%) 11/21 (52.4%) 1.206
[0.496–2.930]
178/344 (51.7%) 1.176
[0.858–1.611]
59/106 (55.7%) 1.376
[0.879–2.155]
25/50 (50.0%) 1.096
[0.601–2.000]
a age, baseline NIHSS, diabetes mellitus, gender, blood glucose, atrial fibrillation;
b age, baseline NIHSS, diabetes mellitus, gender, blood glucose;
c age, baseline NIHSS, diabetes mellitus, blood glucose, atrial fibrillation, coronary heart disease, antithrombotic use at baseline;
d age, diabetes mellitus, systolic blood pressure, blood glucose.
doi:10.1371/journal.pone.0164413.t002
Table 3. Multivariate outcome analyses according to BMI categories.
Outcome measures BMI categories OR [95% CI]
Underweight vs. normal
weight
Overweight vs. normal
weight
Obesity vs. normal
weight
Severe Obesity vs. normal
weight
Favorable outcome (mRS
0–1) a
2.847 [1.000–8.112] 1.094 [0.756–1.583] 1.569 [0.942–2.614] 1.375 [0.660–2.867]
Good outcome (mRS 0–2) b 1.084 [0.361–3.256] 0.791 [0.537–1.166] 0.856 [0.503–1.459] 0.549 [0.263–1.144]
Mortality c 0.441 [0.046–4.270] 1.341 [0.684–2.629] 1.081 [0.400–2.919] 1.605 [0.469–5.486]
Early NIHSS improvement d 1.120 [0.445–2.820] 1.160 [0.835–1.611] 1.419 [0.886–2.273] 1.301 [0.685–2.473]
a baseline NIHSS (p<0.001), age (p = 0.008), blood glucose (p = 0.008);
b age (p<0.001), baseline NIHSS (p<0.001);
c age (p<0.001), baseline NIHSS (p<0.001), blood glucose (p = 0.003);
d blood glucose (p = 0.024), systolic blood pressure (p = 0.040).
doi:10.1371/journal.pone.0164413.t003
BMI and IV Thrombolysis Outcome
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Age, stroke severity and baseline blood glucose were independent predictors of clinical recov-
ery and mortality, whereas systolic blood pressure and blood glucose at admission were signifi-
cantly associated with early NIHSS improvement.
The multivariate analyses showed no differences between overweight, obese and severely
obese patients in reference to normal weight patients regarding functional outcome, mortality
or sICH. Results are presented as odds ratio with 95% confidence intervals. Letters a–d denote
significant associations in multivariate analysis. Abbreviations: BMI (bodymass index), OR
(odds ratio), CI (confidence interval), mRS (modifiedRankin Scale), sICH (symptomatic intra-
cerebral hemorrhage), NIHSS (National Institute of Health Stroke Scale).
Discussion
This multi-center cohort study indicates no significant differences regarding functional out-
come after IVT in normal weight patients compared to overweight, obese and underweight
patients. Likewise,we found a similar risk of mortality and sICH for each BMI group.
Obesity has become a medical and socio-economicburden with epidemic proportions and is
an established risk factor for the incidence of stroke especially in younger patients. Recent studies
surprisingly indicate better functional outcome and less mortality rates in stroke patients with
excess of body weight as compared to their normal weight counterparts (“obesity paradox”) [4].
Data regarding impact of body weight on outcome after IVT are scarce and showed contradic-
tory results hitherto. Sarikaya et al. reported significantly higher rates of mortality and unfavor-
able outcome in 53 obese patients as compared to 251 non-obese patients (BMI<30 kg/m2), but
stated the small size of study cohort study hindering a generalization of the findings and called
for larger studies [16]. Seet et al. observed in their study on 169 patients similar rates of func-
tional recovery among obese (n = 54), overweight, and normal weight patients after IVT [17]. In
the study by Seo et al. assessing 321 Korean patients treated with IVT, being underweightwas
independently associated with poorer long-term survival as compared to patients with normal
body weight [18]. The present IVT study includedmore patients than all 3 abovementioned
studies together [17,19] and found no evidence for different clinical outcomes among normal
weight, underweight, overweight or obese stroke patients. Moreover, we did not observe a differ-
ence in outcomes by comparing obese vs. non-obese patients, neither for clinical recovery nor for
mortality. In addition, we also assessed clinical outcomes in severely obese patients (BMI> 35
kg/m2) separately, but the outcomes were still comparable to normal weight patients. Subse-
quently, we performedmultivariate analyses correcting for potential outcome confounders, but
failed to show an association between clinical endpoints and BMI. The same was also true for the
risk of sICH, which was not associatedwith overweight or obesity. Furthermore, we assessed
early neurological improvement at 24 hours post-treatment (defined as NIHSS score improve-
ment by 40% from baseline) as a predictor of recanalization after thrombolysis and again did
not find significant differences among the 5 body weight groups. In line with this, the rates of
both good clinical outcome (defined as mRS 0 and 1) and favorable clinical outcome (defined as
mRS 0 to 2) at 3 months were similarly distributed among the cohorts. Unfortunately, data about
radiological recanalization were too sparsely available for a firm analysis.
The number of included patients were appropriate in normal weight, overweight and obese
groups (n = 321, 378 and 175, respectively), but probably too low in underweight group
(n = 22). Thus, results for the latter body weight group need a cautious interpretation with
respect to broad confidence intervals in outcome analyses for this group. Further studies are
needed for outcome analyses in these patients, because severe underweight has been shown to
be an independent risk factor for intracranial hemorrhages, poor clinical outcome and mortal-
ity in acute stroke [20–22]. Underweight is also a main indicator of malnutrition, which has a
BMI and IV Thrombolysis Outcome
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high prevalence among older patients and significant association with medical complications
such as renal insufficiency. Lower glomerular filtration has been suggested to be a better risk
indicator for sICH than age in stroke patients treated with IVT [23].
Overall, our data consistently indicate that BMI has no influence on clinical recovery and
mortality in patients undergoing IVT for acute ischemic stroke. This finding is of clinical rele-
vance as it indicates that the current weight-adapted dose regimen for IV alteplase as used in
daily clinical routine is also appropriate for obese and severely obese patients. Furthermore,
our data contradict the popular thesis of “obesity paradox”, which may be an obstacle against
weight reduction in obese patients due to false assumptions (such as beneficial effect of obesity
for stroke prevention). Several reasons may contribute to these discrepant observations. First,
we strictly assessed acute stroke patients treated with IVT with pre-defined outcome analyses
at 3 months. In other studies, the frequency of patients treated with thrombolysis was very low
or not reported, whereas the follow-up duration ranged from 1 week to 10 years [2,24]. Data in
our study were collected prospectively and in a structuredway by trained stroke physicians
allowing good data quality, whereas data collectionwas poorly described in other studies or
data were derived from national healthcare databases [3,25] As consequence,many studies
were not able to correct for relevant outcome predictors such as stroke severity due to data lack
of data [2,3,25,26]. Of note, obese stroke patients tend to be younger with lower stroke severity
due to higher proportion of lacunar infarcts, which may explain better clinical outcomes in
aforementioned studies (selection bias). Thus, the inverse association between BMI and mor-
tality (obesity paradox) disappeared after correcting for stroke severity in some studies.
[27,28]. Treatment bias may be another cause of obesity paradox as it has been shown that phy-
sicians treat obese patients more aggressively than lean patients due to assumed increase of vas-
cular risk [29]. Publication bias may be a further reason for obesity paradox.
Strengths of our study include (i) the relatively large cohort size of stroke patients address-
ing the influence of body weight on outcome after IVT, (ii) good quality of clinical data due to
prospective and standardized assessments, (iii) separate analysis of all BMI groups from under-
weight to severely obese patients, and (iv) the use of comprehensive outcome parameters
including early neurological improvement at 24 hours as a predictor for recanalization.
Nevertheless, several limitations of our study have to be considered: (i) BMI has been criti-
cized for its low accuracy in measuring obesity especially in older people, while waist-to-hip
ratio or waist circumferencemay be more precise for this purpose [30]. (ii) This is an observa-
tional study, thus cautious interpretation is needed especially with respect to causality. To date,
randomized controlled trials are lacking in this field. (iii) Body weight or body height were esti-
mated by relatives or nurses in a subgroup of patients, although recent studies indicate that
estimated weights to be similar to real values [31]. (iv) Because of the limited numbers of
underweight and severely obese patients in our study, results concerning these groups should
be interpreted with caution.
Conclusion
In this study, BMI was not associated with clinical outcomes, risk of sICH or with early neuro-
logical improvement after IVT. Our data suggest that the current weight-adapted dosage
scheme of alteplase is appropriate for different body weight groups and challenge the existence
of obesity paradox after stroke.
Supporting Information
S1 Table. Baseline characteristics according to BMI categories.BMI categories were adopted
according to World Health Organization (WHO) guidelines as follows:<18.5 kg/m2 for
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underweight, 18.5 to 24.9 kg/m2 for normal weight, 25.0 to 29.9 kg/m2 for overweight, 30.0 to
34.9 kg/m2 for obesity and35 kg/m2 for severe obesity. Body weight groups showed unequal
distributions for gender (higher percentage of females in the underweight group), as well as for
hypertension and diabetes (higher prevalence in the excess body weight groups). Obese and
severely obese patients had increased levels of blood glucose and were more often prescribed
antithrombotic drugs. The initial impairment on admission was slightly lower in the high
weight groups. Abbreviations: BMI (bodymass index), IQR (inter quartile range), NIHSS
(National Institute of Health Stroke Scale), CHD (coronary heart disease).
(DOCX)
S2 Table. Patient numbers and study periods for each individual center.
(DOCX)
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